Evolution Wealth Advisors, LLC Akero Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$19.87 - $26.24 $4,192 - $5,536	-211 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$18.65 - $25.46 $6,005 - $8,198	-322 Reduced 60.41%	211 $5,000
Q4 2020 Feb 02, 2021	SELL	$25.12 - $29.89 $4,571 - $5,439	-182 Reduced 25.45%	533 $14,000
Q1 2020 Apr 22, 2020	BUY	$12.8 - $27.05 $2,227 - $4,706	174 Added 32.16%	715 $15,000
Q4 2019 Feb 03, 2020	BUY	$17.37 - $27.27 $9,397 - $14,753	541 New	541 $12,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.